News

2024 Oct 16

NEW MEYER CANCER CENTER CLINICAL RESEARCH LEADERSHIP TEAM

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork- Presbyterian Hospital is pleased to announce a new cancer clinical research leadership team: Vered Stearns, MD is Associate Director for... Read more

2024 Oct 15

Love Your Breasts, Each and Every Year

Previously, women were encouraged to develop a personalized breast cancer screening program starting in their 40s. For some women, that meant no mammogram until age 50. That’s all changed. T he U.S. Preventive Services Task... Read more

Artistic rendition of extrachromosomal DNA and chromosomes

2024 Oct 09

Study Uncovers Mutations and DNA Structures Driving Bladder Cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center . The researchers found that antiviral enzymes that... Read more

This image shows a triple-negative breast cancer cell undergoing cell death after treatment with a combination of chemotherapy and a second targeted drug. Actin in red; mitochondria in green; nuclei in blue. Credit: National Cancer Institute

2024 Oct 04

New Genetic Signatures Can Classify Breast Cancers and Guide Prognosis

Researchers at Weill Cornell Medicine have developed breast cancer cell-of-origin signatures that can better predict both overall and progression-free survival of patients with breast cancer compared to previously developed... Read more

immunofluorescence image of pancreatic cancer cells labeled in various colors

2024 Oct 02

Researchers Develop Insights into KRAS Mutations in Pancreatic Cancers

A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other variants, in part because the mutation appears to lead to less invasiveness and... Read more

Human lung cancer cells stained for various surface markers

2024 Sep 26

Metabolic Reprogramming of T cells May Enhance Checkpoint Inhibitor Therapy

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study led by researchers at Weill Cornell... Read more

2024 Sep 24

New Tool Quantifies Cancer’s Ability to Shape-Shift

A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center ... Read more

2024 Sep 23

Innovative Model Provides Valuable Insights into Prostate Cancer Spread

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads... Read more

man sitting on hospital bed talking to doctor in a chair

2024 Sep 19

New Prostate Biopsy Technique Lowers Infection Risk

A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with... Read more

blue cell and red cell interaction blocked by blue and red antibodies

2024 Sep 15

Long-term Metastatic Melanoma Survival Dramatically Improves on Immunotherapy

Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new... Read more

2024 Sep 12

Meyer Cancer Center Appoints Inaugural DEI Leadership Team

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork- Presbyterian Hospital has appointed a trio of outstanding physicians and researchers to oversee the Center’s first Office of Diversity... Read more

2024 Sep 05

Computational Approach Yields Novel Cancer Targets

Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors. The study , published Sept. 4 in Cell Systems, experimentally... Read more

illustration of the cell nucleus in the interphase (DNA, mRNA, nucleolus and several enzymes)

2024 Aug 15

NIH Grant Will Support Lymphoma Research

Weill Cornell Medicine has received a five-year, $12.4 million grant from the National Cancer Institute, part of the National Institutes of Health, for an extensive program of basic and translational research on the biology... Read more

image of immune cells, stained brown, and ovarian cancer cells with various treatments

2024 Jul 29

Preclinical Study Explores Approved Drug for Ovarian Cancer

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers. The preclinical study ,... Read more

2024 Jul 25

Medicaid Policies Increase Diverse Participation in Cancer Clinical Trials

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania , and... Read more

2024 Jul 24

Blood Test May Guide Use of Multiple Myeloma Immunotherapy

A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according... Read more

2024 Jul 18

Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer

The Parker Institute for Cancer Immunotherapy (PICI) is an unprecedented collaboration between the country’s leading immunotherapy researchers and cancer centers. Founded in 2016 through a $250 million gift from Silicon... Read more

2024 Jul 17

Melanin Matters: How Skin Cancer Affects People of Color

If you have black or brown skin, you have more melanin, or natural pigment, than people with white skin. Extra melanin provides protection from sun-related damage. This defense, however, isn’t perfect. “Having darkly... Read more

2024 Jul 16

How a novel genomic analysis leveraged whole-exome and RNA sequencing to save the life of an elderly patient

An 81-year-old former minor league baseball player with a history of cancer arrived at the emergency department with a fractured forearm and leg pain after a fall at home. Ironically that fracture, and the cutting-edge... Read more

2024 Jul 09

Researchers Customize AI Tools for Digital Pathology

Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute in Boston have developed and tested new artificial intelligence (AI) tools tailored to digital pathology—a rapidly growing field that uses high-... Read more